FULVESTRANT INJECTABLE 50 MG
FULVESTRANT : 50 MG · DIN 02530635 · JAMP PHARMA CORPORATION
Health Canada status: MARKETED
What is FULVESTRANT INJECTABLE?
FULVESTRANT INJECTABLE 50 MG contains FULVESTRANT : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02530635, held by JAMP PHARMA CORPORATION, supplied as SOLUTION for INTRAMUSCULAR administration. Health Canada currently lists it as marketed, status dated 12-Sep-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is FULVESTRANT INJECTABLE used for?
Fulvestrant Injectable (fulvestrant) is indicated for the treatment of estrogen receptor-positive, human epidermal growth receptor 2 (HER2)-negative locally advanced or metastatic breast cancer in postmenopausal women not previously treated with endocrine therapy, or hormonal treatment of locally advanced or metastatic breast cancer in postmenopausal women, regardless of age, who have disease progression following prior anti-estrogen therapy.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02530635 |
|---|---|
| Brand name | FULVESTRANT INJECTABLE |
| Generic / active ingredient | FULVESTRANT : 50 MG |
| Manufacturer | JAMP PHARMA CORPORATION |
| Strength | 50 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAMUSCULAR |
| Schedule | Prescription |
| ATC code | L02BA03 FULVESTRANT |
| AHFS class | 10:00.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 12-Sep-2024 |
| Original market date | 2024-09-12 00:00:00 |
How is it stored and handled?
null
How is it supplied?
null
What can be used instead?
Other Canadian products sharing ATC code L02BA03 FULVESTRANT. 6 of 12 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FASLODEX | 50 MG | SOLUTION | ASTRAZENECA CANADA INC | MARKETED | DIN 02248624 |
| FULVESTRANT INJECTION | 250 MG / 5 ML | SOLUTION | STERIMAX INC | MARKETED | DIN 02558971 |
| FULVESTRANT INJECTION | 50 MG | SOLUTION | FORMATIVE PHARMA INC. | MARKETED | DIN 02536293 |
| FULVESTRANT INJECTION | 50 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02483610 |
| TEVA-FULVESTRANT INJECTION | 50 MG | SOLUTION | TEVA CANADA LIMITED | MARKETED | DIN 02460130 |
| ACT FULVESTRANT | 50 MG | SOLUTION | ACTAVIS PHARMA COMPANY | CANCELLED PRE MARKET | DIN 02463075 |
| APO-FULVESTRANT | 50 MG | SOLUTION | APOTEX INC | APPROVED | DIN 02486350 |
| FULVESTRANT INJECTION | 50 MG | SOLUTION | ACCORD HEALTHCARE INC | CANCELLED POST MARKET | DIN 02486792 |
| FULVESTRANT INJECTION | 50 MG | SOLUTION | AURO PHARMA INC | APPROVED | DIN 02533111 |
| FULVESTRANT INJECTION | 50 MG | SOLUTION | EUGIA PHARMA INC. | APPROVED | DIN 02536668 |
Who else supplies FULVESTRANT worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FULVESTRANT appears in 105 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.